James RPh - Medadvisor Executive Relations
| MDR Stock | 0.02 0.00 0.00% |
Executive
James RPh is Executive Relations of Medadvisor
| Phone | 781 425 6611 |
| Web | https://www.medadvisorsolutions.com |
Medadvisor Management Efficiency
The company has return on total asset (ROA) of (0.1177) % which means that it has lost $0.1177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.406) %, meaning that it generated substantial loss on money invested by shareholders. Medadvisor's management efficiency ratios could be used to measure how well Medadvisor manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| AGIA BCom | Falcon Metals | N/A | |
| Jeremy OBrien | Air New Zealand | N/A | |
| LLB BCom | Air New Zealand | N/A | |
| Mathew Bolland | Air New Zealand | N/A | |
| Brent Polites | Autosports Group | N/A | |
| Roger MAusIMM | Centaurus Metals | N/A | |
| Wayne Mausimm | Centaurus Metals | N/A | |
| Mike Williams | Air New Zealand | N/A | |
| Jennifer Page | Air New Zealand | N/A | |
| Kim Cootes | Air New Zealand | N/A | |
| Captain Morgan | Air New Zealand | N/A | |
| PMP MSc | Centaurus Metals | 45 | |
| Julia Oliveira | Centaurus Metals | N/A | |
| Alexis Munoz | Marimaca Copper Corp | N/A | |
| Solange Gonzalez | Marimaca Copper Corp | N/A | |
| Alexandria Marren | Air New Zealand | 64 | |
| Caroline Gatenby | Autosports Group | N/A | |
| Leanne Geraghty | Air New Zealand | N/A | |
| Nicolas Cookson | Marimaca Copper Corp | N/A | |
| BSc BCom | Air New Zealand | N/A | |
| Bruno MSc | Centaurus Metals | 47 | |
Management Performance
| Return On Equity | -2.41 | ||||
| Return On Asset | -0.12 |
Medadvisor Leadership Team
Elected by the shareholders, the Medadvisor's board of directors comprises two types of representatives: Medadvisor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medadvisor. The board's role is to monitor Medadvisor's management team and ensure that shareholders' interests are well served. Medadvisor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medadvisor's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jamal Butt, Chief UK | ||
| Wayne Marinoff, EGM Marketing | ||
| Craig Schnuriger, Acting Officer | ||
| Vinod Subramanian, Chief Officer | ||
| Anshu Raghuvanshi, Joint Secretary | ||
| Naomi Lawrie, Company Counsel | ||
| James RPh, Executive Relations | ||
| Sean Slattery, CFO Secretary | ||
| Brian Peterson, President US | ||
| Anshu LLB, Joint Secretary | ||
| Rick Ratliff, MD CEO | ||
| Richard Ratliff, MD CEO | ||
| Sarah Sweeney, Senior Marketing | ||
| John Ciccio, Chief Adheris | ||
| Ruba ElAfifi, Chief Officer | ||
| AGIA BA, Company Secretary |
Medadvisor Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medadvisor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.41 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | (0.21) % | ||||
| Current Valuation | 19.19 M | ||||
| Shares Outstanding | 636.52 M | ||||
| Shares Owned By Insiders | 36.61 % | ||||
| Shares Owned By Institutions | 34.35 % | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 0.22 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medadvisor Stock Analysis
When running Medadvisor's price analysis, check to measure Medadvisor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medadvisor is operating at the current time. Most of Medadvisor's value examination focuses on studying past and present price action to predict the probability of Medadvisor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medadvisor's price. Additionally, you may evaluate how the addition of Medadvisor to your portfolios can decrease your overall portfolio volatility.